Advertisement
The leading life science news channel in the Nordic region.
Biotech Business - September 24, 2024
The company has received a substantial investment from Kempestiftelserna.
Business Award - September 23, 2024
This year in Malmö two awards in two different competitions were handed out, the Nordic Star pitch competition and the Innovation Poster exhibition.
MedTech Business - September 20, 2024
For seriously ill children and adolescents, intravenous drip stands can significantly hinder mobility.
Business article - September 19, 2024
A new bioanalytical laboratory, creating up to 140 new jobs for researchers and laboratory staff, will be established during the last quarter of 2025.
Clinical Trials - September 19, 2024
Anocca will present its novel platform approach to therapeutic TCR discovery and preclinical data for its lead TCR-T cell therapy product at the European Society of Medical Oncology (ESMO) Congress 2024.
Clinical Trials - September 18, 2024
The results further demonstrate the potential for TILT-123 as an intravenous therapy.
Clinical Trials - September 18, 2024
The company has agreed with the investigators conducting the LUNGVAC trial to discontinue patient recruitment.
Clinical Trials - September 17, 2024
Medivir has presented positive, mature data from its ongoing phase 1b / 2a study of fostroxacitabine bralpamide (fostrox) + Lenvima in advanced liver cancer at the ESMO Congress in Barcelona, Spain.
Agreement - September 17, 2024
Navamedic has partnered with Alex Therapeutics to aid in Parkinson’s treatment management.
Biotech Business - September 17, 2024
Oncopeptides has announced that it has signed an exclusive license and supply agreement with SCBIO, a Korean pharmaceutical company for the commercialization of Oncopeptides’ flagship drug Pepaxti in South Korea.
This site uses cookies